Evidence map›Paper›PMID 36182704›Full record

ArticleCell2022

Primate hemorrhagic fever-causing arteriviruses are poised for spillover to humans.

Cody J Warren, Shuiqing Yu, Douglas K Peters, Arturo Barbachano-Guerrero, Qing Yang, Bridget L Burris, Gabriella Worwa, I-Chueh Huang, Gregory K Wilkerson, Tony L Goldberg and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Targeting PRMT7-mediated monomethylation of MAVS enhances antiviral innate immune responses and inhibits RNA virus replication.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Heliyon · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Cody J WarrenBioFrontiers Institute, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80303, USA.
Shuiqing YuIntegrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA.
Douglas K PetersBioFrontiers Institute, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80303, USA.
Arturo Barbachano-GuerreroBioFrontiers Institute, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80303, USA.
Qing YangBioFrontiers Institute, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80303, USA.
Bridget L BurrisDepartment of Comparative Medicine, Michale E. Keeling Center for Comparative Medicine and Research, The University of Texas MD Anderson Cancer Center, Bastrop, TX 78602, USA.
Gabriella WorwaIntegrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA.
I-Chueh HuangIntegrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA.
Gregory K WilkersonDepartment of Comparative Medicine, Michale E. Keeling Center for Comparative Medicine and Research, The University of Texas MD Anderson Cancer Center, Bastrop, TX 78602, USA.
Tony L GoldbergDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI 53706, USA.
Jens H KuhnIntegrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA. Electronic address: kuhnjens@mail.nih.gov.
Sara L SawyerBioFrontiers Institute, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80303, USA. Electronic address: ssawyer@colorado.edu.
University of Colorado Boulder · USNational Institute of Allergy and Infectious Diseases · USThe University of Texas MD Anderson Cancer Center · USNational Institutes of Health · USUniversity of Wisconsin–Madison · US

Funding

Breaking the Barrier to an HIV VaccineDP1AI175471 · NIAID · UNIVERSITY OF COLORADO · PI Sara Sawyer · 2022 to 2026
$5.5M
Hunting the HIV-1 UnicornDP1DA046108 · NIDA · UNIVERSITY OF COLORADO · PI SAWYER, SARA · 2018 to 2022
$4.5M
Characterizing Host-Virus Interactions in a New HIV Model OrganismR01OD034046 · OD · UNIVERSITY OF COLORADO · PI Sara Sawyer · 2022 to 2026
$3.6M
Host genetic barriers to virus spilloverR01AI137011 · NIAID · UNIVERSITY OF COLORADO · PI SAWYER, SARA · 2018 to 2022
$2.1M
Mechanisms in Polyomavirus AssemblyR01AI151636 · NIAID · UNIVERSITY OF COLORADO · PI GARCEA, ROBERT L · 2020 to 2024
$1.9M
FACSAria Fusion Cell SorterS10OD021601 · OD · UNIVERSITY OF COLORADO · PI LIU, XUEDONG · 2016 to 2016
$599k
Investigating CD4 as a species-specific barrier to transmitted/founder HIV-1 infectionF32GM125442 · NIGMS · UNIVERSITY OF COLORADO · PI WARREN, CODY JAY · 2018 to 2019
$120k
Identifying genetic barriers to animal virus replication in human cells: Insights into zoonosisK99AI151256 · NIAID · UNIVERSITY OF COLORADO · PI WARREN, CODY JAY · 2021 to 2022
$118k
Intramural NIH HHS Z99 AI999999NIAID NIH HHS DP1 AI175471NIAID NIH HHS HHSN272201800013CNIAID NIH HHS K99 AI151256NIAID NIH HHS R01 AI137011NIAID NIH HHS R01 AI151636NIDA NIH HHS DP1 DA046108NIGMS NIH HHS F32 GM125442NIH HHS R01 OD034046NIH HHS S10 OD021601
6 · The paper itself

Abstract

Simian arteriviruses are endemic in some African primates and can cause fatal hemorrhagic fevers when they cross into primate hosts of new species. We find that CD163 acts as an intracellular receptor for simian hemorrhagic fever virus (SHFV; a simian arterivirus), a rare mode of virus entry that is shared with other hemorrhagic fever-causing viruses (e.g., Ebola and Lassa viruses). Further, SHFV enters and replicates in human monocytes, indicating full functionality of all of the human cellular proteins required for viral replication. Thus, simian arteriviruses in nature may not require major adaptations to the human host. Given that at least three distinct simian arteriviruses have caused fatal infections in captive macaques after host-switching, and that humans are immunologically naive to this family of viruses, development of serology tests for human surveillance should be a priority.

Indexed as

ArterivirusHemorrhagic Fevers, ViralAnimalsHumansMacacaPrimatesViral ZoonosesVirus InternalizationVirus Replicationarms racearterivirusesCD163 receptordisease emergencehemorrhagic feverpositive selectionprimatesvirus entryvirus evolutionzoonosis

Identifiers

PMID36182704
PMCPMC9588614
OpenAlexW4298150007

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.